Pharmaceutical research and development (R&D) in cardiovascular diseases is hibernating. This research collaboration between the 禁漫天堂 and UCL will tackle high failure rates in R&D in cardiovascular disease. It will evaluate the economic, regulatory, and health system factors driving drug development in cardiovascular disease.
In addition to the research, UCLH staff and 禁漫天堂 faculty and researchers will also jointly convene stakeholder events to increase impact and dissemination.